
WASHINGTON, April 29 (UPI) -- The U.S. Food and Drug Administration announced the nationwide recall of Libimax brand sexual supplement due to a safety hazard.
The FDA said the Nature & Health Co. of Brea, Calif., initiated the voluntary recall because a FDA lab analysis showed the product contains tadalafil, an active ingredient of an FDA-approved drug for erectile dysfunction. The federal agency said tadalafil can interact with nitrates found in some prescription drugs, lowering blood pressure to dangerous levels.
According to the FDA, people with diabetes, high blood pressure, high cholesterol or heart disease often take nitrates.
The recalled Libimax is sold as a 1 capsule individual pack or in 10-capsule and 20-capsule plastic bottles in retail stores in California, Georgia, Illinois, Texas, and Ohio. The FDA said the product label neither states it contains tadalafil, nor warns consumers with high blood pressure not to ingest the product.
"Consumers who have Libimax in their possession should stop using it immediately and contact their physician if they experienced any problem that may be related to taking this product," the FDA said.
Consumers with questions can contact the company at 714-257-1800.
|
|
|
| Additional Science News Stories | |
CAMBRIDGE, Ohio, Feb. 9 (UPI) --
An Ohio father was charged Thursday with felony domestic violence for allegedly putting his 3-year-old son in a clothes dryer and turning it on.
|
DENVER, Feb. 9 (UPI) --
Colorado news anchor Kyle Dyer has undergone reconstructive surgery after being bitten in the face by an Argentine mastiff during a broadcast.
|
BUDAPEST, Hungary, Feb. 9 (UPI) --
A zebra's black and white stripes, puzzling biologists for centuries, may have been an evolutionary defense against biting insects, Hungarian researchers say.
|
Man charged for throwing pennies at car ... Martha Washington's dress fabric for sale ... Mixer heist gets mix of probation, service ... 'Survivor' invades Northwestern classroom ... Watercooler stories from UPI.
|
| Stories | Photos | People | Comments |
View Caption